As an example, breast cancer is often characterized, in part, by the dysregulation of cell cycle (i.e., E2F and CDK4/6), DNA repair (i.e., BRCA1 and p53), and epigenetic modifying (i.e., EZH2) proteins (2, 3, 4, 5). This evidence concerns the gene TP53 and breast carcinoma.